CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $320,000 | +15.9% | 111,757 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $276,000 | -29.2% | 111,757 | +3.5% | 0.00% | -50.0% |
Q1 2017 | $390,000 | -10.6% | 108,015 | -12.2% | 0.00% | 0.0% |
Q4 2016 | $436,000 | -16.6% | 123,053 | -5.0% | 0.00% | 0.0% |
Q3 2016 | $523,000 | -17.1% | 129,574 | -9.9% | 0.00% | -33.3% |
Q2 2016 | $631,000 | -13.3% | 143,774 | -25.3% | 0.00% | 0.0% |
Q1 2016 | $728,000 | -59.6% | 192,574 | +67.4% | 0.00% | -62.5% |
Q4 2015 | $1,804,000 | +82.0% | 115,044 | +22.3% | 0.01% | +100.0% |
Q3 2015 | $991,000 | -67.4% | 94,048 | -21.9% | 0.00% | -66.7% |
Q2 2015 | $3,036,000 | -22.1% | 120,368 | -14.0% | 0.01% | -25.0% |
Q1 2015 | $3,899,000 | +99.6% | 139,913 | +30.7% | 0.02% | +100.0% |
Q4 2014 | $1,953,000 | +48.3% | 107,029 | +5.3% | 0.01% | +33.3% |
Q3 2014 | $1,317,000 | -20.5% | 101,655 | +0.1% | 0.01% | -14.3% |
Q2 2014 | $1,657,000 | +5.7% | 101,544 | +14.4% | 0.01% | 0.0% |
Q1 2014 | $1,568,000 | -29.2% | 88,747 | -2.9% | 0.01% | -22.2% |
Q4 2013 | $2,214,000 | -43.1% | 91,438 | -16.7% | 0.01% | -47.1% |
Q3 2013 | $3,891,000 | +129.6% | 109,824 | +1.2% | 0.02% | +88.9% |
Q2 2013 | $1,695,000 | – | 108,556 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |